Wednesday June 21, 2023
Laboratory diagnostics – where after Covid?
Diagnostic labs saw massive growth during Covid. How has this changed the long-term outlook for the sector? For instance, has Covid enabled the sector to successfully build new relationships with government and public payors? This session also explores growth opportunities in outsourcing, new tech, verticalisation and emerging markets
Speakers include:
Jerome Thill, Deputy CEO, Cerba
Wolf Kupatt, CEO, Amedes
Staffan Ternstrom, COO Diagnostic Services, Medicover






Explore similar sessions
The evolution in Primary Care
The huge primary care sector in Europe holds the key to outpatient consolidation. Here we look at how operators are pairing it with digital and telehealth, pharmacies and imaging, and...








Opportunities in Oncology
There is still a long way to go to build capacity in oncology care, but with huge investor interest, linked to the close synergies with imaging diagnostics, the opportunities are...


Opportunities in Ophthalmology
Ophthalmology continues to be a big area of investor interest with considerable scope for consolidation. Governments are increasingly outsourcing cataract operations and the sector is starting to unlock the potential...





